Xilio Common Stock vs Current Deferred Revenue Analysis

XLO Stock

USD 0.92 0.02 2.13%

Xilio Development financial indicator trend analysis is more than just analyzing Xilio Development current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Xilio Development is a good investment. Please check the relationship between Xilio Development Common Stock and its Current Deferred Revenue accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xilio Development. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.

Common Stock vs Current Deferred Revenue

Common Stock vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Xilio Development Common Stock account and Current Deferred Revenue. At this time, the significance of the direction appears to have pay attention.

The correlation between Xilio Development's Common Stock and Current Deferred Revenue is -1.0. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Xilio Development, assuming nothing else is changed. The correlation between historical values of Xilio Development's Common Stock and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Xilio Development are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Common Stock i.e., Xilio Development's Common Stock and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

-1.0

Relationship Direction	Negative
Relationship Strength	Strong

View All Relationships

Common Stock

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from Xilio Development's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Xilio Development current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xilio Development. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.At this time, Xilio Development's Enterprise Value Over EBITDA is very stable compared to the past year. As of the 22nd of November 2024, Enterprise Value Multiple is likely to grow to 0.26, while Selling General Administrative is likely to drop about 21.2 M.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	75.0M	89.1M	79.1M	69.7M
Cost Of Revenue	1.5M	1.8M	1.9M	1.4M

Total Operating Expenses Cost Of Revenue

Xilio Development fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.15	0.31	0.35	0.96	0.68	0.83	0.61	-0.96	-0.47	-0.05	0.95	0.6	0.01	0.84	-0.22	0.95	-0.23	-0.69	0.37	0.94	0.68	-0.7	0.83	0.33	0.95
Short Long Term Debt Total	0.15		-0.31	-0.1	-0.08	-0.5	-0.39	0.05	-0.23	0.61	0.82	0.3	0.07	-0.16	0.27	0.59	0.3	0.41	0.5	-0.37	-0.05	-0.33	0.55	-0.4	0.63	0.29
Other Current Liab	0.31	-0.31		0.95	0.43	0.76	0.59	0.86	-0.22	-0.84	0.14	0.19	0.85	-0.57	0.2	-0.81	0.19	-0.33	-0.71	0.97	0.57	0.86	-0.59	0.59	0.08	0.19
Total Current Liabilities	0.35	-0.1	0.95		0.43	0.7	0.52	0.91	-0.25	-0.78	0.28	0.23	0.9	-0.77	0.14	-0.8	0.23	-0.33	-0.66	0.88	0.53	0.82	-0.53	0.52	0.09	0.23
Total Stockholder Equity	0.96	-0.08	0.43	0.43		0.82	0.94	0.6	-0.94	-0.64	-0.2	0.91	0.58	-0.01	0.75	-0.41	0.91	-0.21	-0.84	0.46	0.95	0.82	-0.85	0.93	0.11	0.91
Other Liab	0.68	-0.5	0.76	0.7	0.82		0.95	0.72	-0.57	-0.96	-0.38	0.51	0.7	-0.27	0.39	-0.83	0.51	-0.52	-1.0	0.78	0.81	0.95	-0.97	0.95	-0.16	0.52
Net Tangible Assets	0.83	-0.39	0.59	0.52	0.94	0.95		0.63	-0.76	-0.84	-0.4	0.71	0.61	-0.04	0.6	-0.63	0.71	-0.42	-0.96	0.64	0.91	0.9	-0.97	1.0	-0.05	0.71
Property Plant And Equipment Net	0.61	0.05	0.86	0.91	0.6	0.72	0.63		-0.48	-0.7	0.3	0.46	1.0	-0.58	0.47	-0.62	0.46	-0.46	-0.67	0.87	0.74	0.81	-0.56	0.63	0.4	0.46
Net Debt	-0.96	-0.23	-0.22	-0.25	-0.94	-0.57	-0.76	-0.48		0.34	-0.02	-1.0	-0.47	-0.12	-0.88	0.09	-1.0	-0.03	0.59	-0.25	-0.89	-0.62	0.61	-0.76	-0.33	-1.0
Retained Earnings	-0.47	0.61	-0.84	-0.78	-0.64	-0.96	-0.84	-0.7	0.34		0.37	-0.28	-0.68	0.4	-0.17	0.94	-0.28	0.54	0.95	-0.84	-0.65	-0.92	0.91	-0.84	0.28	-0.29
Accounts Payable	-0.05	0.82	0.14	0.28	-0.2	-0.38	-0.4	0.3	-0.02	0.37		0.09	0.32	-0.41	0.15	0.31	0.09	0.44	0.42	0.05	-0.06	-0.11	0.53	-0.41	0.65	0.08
Cash	0.95	0.3	0.19	0.23	0.91	0.51	0.71	0.46	-1.0	-0.28	0.09		0.45	0.12	0.88	-0.03	1.0	0.09	-0.54	0.21	0.86	0.58	-0.55	0.7	0.36	1.0
Non Current Assets Total	0.6	0.07	0.85	0.9	0.58	0.7	0.61	1.0	-0.47	-0.68	0.32	0.45		-0.58	0.46	-0.6	0.45	-0.47	-0.64	0.86	0.73	0.78	-0.54	0.61	0.43	0.45
Non Currrent Assets Other	0.01	-0.16	-0.57	-0.77	-0.01	-0.27	-0.04	-0.58	-0.12	0.4	-0.41	0.12	-0.58		0.34	0.62	0.12	0.28	0.25	-0.42	-0.01	-0.36	0.12	-0.04	0.12	0.11
Other Assets	0.84	0.27	0.2	0.14	0.75	0.39	0.6	0.47	-0.88	-0.17	0.15	0.88	0.46	0.34		0.15	0.88	0.05	-0.38	0.31	0.85	0.46	-0.39	0.6	0.67	0.88
Long Term Debt	-0.22	0.59	-0.81	-0.8	-0.41	-0.83	-0.63	-0.62	0.09	0.94	0.31	-0.03	-0.6	0.62	0.15		-0.03	0.55	0.82	-0.75	-0.39	-0.79	0.76	-0.63	0.45	-0.04
Cash And Short Term Investments	0.95	0.3	0.19	0.23	0.91	0.51	0.71	0.46	-1.0	-0.28	0.09	1.0	0.45	0.12	0.88	-0.03		0.09	-0.54	0.21	0.86	0.58	-0.55	0.7	0.36	1.0
Common Stock Shares Outstanding	-0.23	0.41	-0.33	-0.33	-0.21	-0.52	-0.42	-0.46	-0.03	0.54	0.44	0.09	-0.47	0.28	0.05	0.55	0.09		0.49	-0.45	-0.27	-0.31	0.49	-0.42	0.07	0.09
Non Current Liabilities Total	-0.69	0.5	-0.71	-0.66	-0.84	-1.0	-0.96	-0.67	0.59	0.95	0.42	-0.54	-0.64	0.25	-0.38	0.82	-0.54	0.49		-0.72	-0.8	-0.94	0.99	-0.96	0.22	-0.55
Capital Lease Obligations	0.37	-0.37	0.97	0.88	0.46	0.78	0.64	0.87	-0.25	-0.84	0.05	0.21	0.86	-0.42	0.31	-0.75	0.21	-0.45	-0.72		0.64	0.84	-0.63	0.64	0.19	0.21
Other Current Assets	0.94	-0.05	0.57	0.53	0.95	0.81	0.91	0.74	-0.89	-0.65	-0.06	0.86	0.73	-0.01	0.85	-0.39	0.86	-0.27	-0.8	0.64		0.84	-0.79	0.91	0.35	0.87
Other Stockholder Equity	0.68	-0.33	0.86	0.82	0.82	0.95	0.9	0.81	-0.62	-0.92	-0.11	0.58	0.78	-0.36	0.46	-0.79	0.58	-0.31	-0.94	0.84	0.84		-0.88	0.9	-0.03	0.59
Total Liab	-0.7	0.55	-0.59	-0.53	-0.85	-0.97	-0.97	-0.56	0.61	0.91	0.53	-0.55	-0.54	0.12	-0.39	0.76	-0.55	0.49	0.99	-0.63	-0.79	-0.88		-0.97	0.27	-0.56
Net Invested Capital	0.83	-0.4	0.59	0.52	0.93	0.95	1.0	0.63	-0.76	-0.84	-0.41	0.7	0.61	-0.04	0.6	-0.63	0.7	-0.42	-0.96	0.64	0.91	0.9	-0.97		-0.05	0.71
Property Plant And Equipment Gross	0.33	0.63	0.08	0.09	0.11	-0.16	-0.05	0.4	-0.33	0.28	0.65	0.36	0.43	0.12	0.67	0.45	0.36	0.07	0.22	0.19	0.35	-0.03	0.27	-0.05		0.35
Total Current Assets	0.95	0.29	0.19	0.23	0.91	0.52	0.71	0.46	-1.0	-0.29	0.08	1.0	0.45	0.11	0.88	-0.04	1.0	0.09	-0.55	0.21	0.87	0.59	-0.56	0.71	0.35

Click cells to compare fundamentals

Xilio Development Account Relationship Matchups

Pair Trading with Xilio Development

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Xilio Development position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will appreciate offsetting losses from the drop in the long position's value.

Moving against Xilio Stock

0.66	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.66	MTEM	Molecular Templates	Pair Corr
0.63	TPST	Tempest Therapeutics	Pair Corr
0.58	ME	23Andme Holding	Pair Corr
0.57	NKTX	Nkarta Inc	Pair Corr

The ability to find closely correlated positions to Xilio Development could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xilio Development when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xilio Development - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xilio Development to buy it.

The correlation of Xilio Development is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xilio Development moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xilio Development moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Xilio Development can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Xilio Development offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Xilio Development's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xilio Development Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xilio Development Stock:

How To Invest In Xilio

Details

Is Xilio Stock a good investment?

Details

What is Xilio Development's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xilio Development. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.

You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xilio Development. If investors know Xilio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xilio Development listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.55)

Revenue Per Share

0.105

Return On Assets

(0.53)

Return On Equity

(1.71)

The market value of Xilio Development is measured differently than its book value, which is the value of Xilio that is recorded on the company's balance sheet. Investors also form their own opinion of Xilio Development's value that differs from its market value or its book value, called intrinsic value, which is Xilio Development's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xilio Development's market value can be influenced by many factors that don't directly affect Xilio Development's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Xilio Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xilio Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xilio Development's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Xilio Common Stock vs Current Deferred Revenue Analysis

Common Stock vs Current Deferred Revenue

Common Stock vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Common Stock

Current Deferred Revenue

Xilio Development fundamental ratios Correlations

Xilio Development Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pair Trading with Xilio Development

Moving against Xilio Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Invested Capital	+ 1.0	Net Tangible Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Liab	+ 0.99	Non Current Liabilities Total

Total Current Assets	- 1.0	Net Debt
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Non Current Liabilities Total	- 1.0	Other Liab
Net Invested Capital	- 0.97	Total Liab
Total Liab	- 0.97	Net Tangible Assets